Cargando…

Mixed cryoglobulinaemia vasculitis after sustained hepatitis C virological response with direct-acting antivirals

Mixed cryoglobulinaemia (MCG) is one of the most severe extrahepatic hepatitis C virus (HCV)-associated complications, and could involve several organs, including the kidney. MCG prognosis relies on HCV response to antiviral treatment and has changed over the last years, especially after the introdu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barbieri, Diego, García-Prieto, Ana, Torres, Esther, Verde, Eduardo, Goicoechea, Marian, Luño, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Glomerular Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543977/ https://www.ncbi.nlm.nih.gov/pubmed/31198535 http://dx.doi.org/10.1093/ckj/sfy055

Ejemplares similares

Predictive factors of renal involvement in cryoglobulinaemia: a retrospective study of 153 patients
por: Coliche, Vladimir, et al.
Publicado: (2018)

Intravenous cyclophosphamide and oral prednisolone is a safe and effective treatment option for idiopathic membranous nephropathy
por: Mathrani, Vinod, et al.
Publicado: (2017)

Collapsing glomerulopathy: a 30-year perspective and single, large center experience
por: Nicholas Cossey, L., et al.
Publicado: (2017)

Assessment of active tubulointerstitial nephritis in non-scarred renal cortex improves prediction of renal outcomes in patients with IgA nephropathy
por: Rankin, Alastair J, et al.
Publicado: (2018)

First report of collapsing variant of focal segmental glomerulosclerosis triggered by arbovirus: dengue and Zika virus infection
por: Araújo, Stanley de Almeida, et al.
Publicado: (2018)

Mixed Cryoglobulinaemia Vasculitis Treated with Obinutuzumab in a Patient Allergic to Rituximab
por: Gaudêncio, Margarida, et al.
Publicado: (2021)

Direct-acting antiviral therapy improves kidney survival in hepatitis C virus-associated cryoglobulinaemia: the RENALCRYOGLOBULINEMIC study
por: Pérez de José, Ana, et al.
Publicado: (2020)

AZD-1222/tozinameran: Flares of mixed cryoglobulinaemia vasculitis: 6 case reports
Publicado: (2022)

An interesting rash: leucocytoclastic vasculitis with type 2 cryoglobulinaemia
por: Mannu, Gurdeep Singh
Publicado: (2010)

A Case of Cutaneous Vasculitis with Underlying Hepatitis C and Cryoglobulinaemia
por: Groves, Cheryl, et al.
Publicado: (2008)

Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience
por: Lauletta, Gianfranco, et al.
Publicado: (2017)

Successful Treatment of Cryoglobulinaemia with Rituximab
por: Choudhry, M., et al.
Publicado: (2012)

54. Type I cryoglobulinaemia: vascular occlusion and thrombosis
por: Zacharias, Hannah, et al.
Publicado: (2018)

Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
por: Noureddin, Mazen, et al.
Publicado: (2018)

Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy
por: Cartwright, Emily J., et al.
Publicado: (2023)

PB2549: CO-EXISTENT COLD AGGLUTININ DISEASE AND CRYOGLOBULINAEMIA
por: Japzon, Nicole, et al.
Publicado: (2023)

Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment
por: Hahn, Katherine J., et al.
Publicado: (2015)

Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct‐Acting Antivirals for Hepatitis C
por: Pan, Jason J., et al.
Publicado: (2018)

Liver stiffness regression after sustained virological response by direct-acting antivirals reduces the risk of outcomes
por: Piedade, Juliana, et al.
Publicado: (2021)

Salvage therapy in cancer patients with hepatitis C without sustained virologic response after direct‐acting antivirals—A prospective study
por: Pritchard, Haley, et al.
Publicado: (2019)

Obesity and chronic kidney disease progression—the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1
por: Barbieri, Diego, et al.
Publicado: (2018)

High sustained virological response rates using imported generic direct acting antiviral treatment for hepatitis C
por: Hill, Andrew, et al.
Publicado: (2017)

Effect of Low Positive End of Treatment Viral Load with Direct-Acting Antiviral Therapy on Sustained Virologic Response
por: Pal, Vabhave, et al.
Publicado: (2020)

Hepatocellular carcinoma after a sustained virological response by direct‐acting antivirals harbors TP53 inactivation
por: Imamura, Taisuke, et al.
Publicado: (2022)

Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid
por: Pham, Timothy T., et al.
Publicado: (2018)

Persistent pruritus as a rare and potentially serious manifestation of liver involvement in autosomal dominant polycystic kidney disease
por: García-Prieto, Ana, et al.
Publicado: (2018)

Fibrillary comma-shaped electron-dense organized glomerular deposits associated with cryoglobulinaemia
por: Stabellini, Nevio, et al.
Publicado: (2008)

Sustained Virologic Response with Direct Acting Antivirals in HIV Coinfected Hepatitis C Patients and Its Effect on Liver Fibrosis
por: Lebron, Dora, et al.
Publicado: (2017)

Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
por: D’Ambrosio, Roberta, et al.
Publicado: (2021)

2222. Impact of Sustained Virologic Response Achieved Through Newer Direct Acting Antivirals in Hepatitis C Infection on Diabetes Mellitus
por: Mada, Pradeep Kumar, et al.
Publicado: (2018)

Direct-acting antivirals trigger a favorable, sustained virological response in patients with chronic hepatitis C infections and hepatocellular carcinoma
por: Sohn, Won
Publicado: (2021)

Cryoglobulinaemia in Egyptian Patients with Extrahepatic Cutaneous Manifestations of Chronic Hepatitis C Virus Infection
por: Hegab, Doaa Salah, et al.
Publicado: (2015)

Predictors Associated with Increase in Skeletal Muscle Mass after Sustained Virological Response in Chronic Hepatitis C Treated with Direct Acting Antivirals
por: Yoh, Kazunori, et al.
Publicado: (2017)

A Patient with HCV Infection and a Sustained Virological Response to Direct-acting Antiviral Treatment Who Developed Inclusion Body Myositis
por: Kuwano, Toru, et al.
Publicado: (2018)

Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatment
por: Imai, Kenji, et al.
Publicado: (2020)

Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials
por: Struble, Kimberly, et al.
Publicado: (2019)

Risk factors for liver‐related mortality of patients with hepatitis C virus after sustained virologic response to direct‐acting antiviral agents
por: Hattori, Nobuhiro, et al.
Publicado: (2022)

Effects of hepatitis C virus genotypes and viral load on glucose and lipid metabolism after sustained virological response with direct-acting antivirals
por: Sparvoli, Jucéli Márcia Hendges, et al.
Publicado: (2023)

Monoclonal gammopathy of renal significance presenting with cryoglobulinaemia type I associated severe thrombotic microangiopathy
por: Hesius, Eva, et al.
Publicado: (2022)

Delayed surgical strategy for type A aortic dissection associated with acute hepatitis C cryoglobulinaemia
por: Ahmed-Issap, Amber, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a1s8ja63luekl6a4kinrdau340